ETI
BMY icon

Enterprise Trust & Investment’s Bristol-Myers Squibb BMY Stock Holding History

Enterprise Trust & Investment’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$15K Buy
+194
New +$14.8K 0.01% 193
2020
Q1 		– Sell
-18,750
Closed -$1.2M – 189
2019
Q4 		$1.2M Buy
+18,750
New +$1.07M 0.67% 44

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Enterprise Trust & Investment's BMY Position: Q2 2022 in Review

Enterprise Trust & Investment opened a new position in Bristol-Myers Squibb (BMY) in Q2 2022: 194 shares worth $15K. The stake represents 0.01% of the portfolio and ranks #193 among its holdings. This is a return to the name: Enterprise Trust & Investment previously reported a position in BMY as recently as Q4 2019.

Enterprise Trust & Investment first reported a position in BMY in Q4 2019 and has held it in 2 quarters since. The position peaked at $1.2M in Q4 2019. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Enterprise Trust & Investment held 194 shares of Bristol-Myers Squibb worth $15K as of Q2 2022.
  • Bristol-Myers Squibb was a new Enterprise Trust & Investment position in Q2 2022.
  • Bristol-Myers Squibb made up 0.01% of Enterprise Trust & Investment's portfolio in Q2 2022, its #193 holding.
  • Enterprise Trust & Investment first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 2 quarters since.
  • Enterprise Trust & Investment's Bristol-Myers Squibb position peaked at $1.2M in Q4 2019.
  • 2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.